UPenn Perelman School of Medicine: Science Behind Genetic Testing for Identifying Risk of Opioid Misuse Remains Unproven
January 11, 2025
January 11, 2025
PHILADELPHIA, Pennsylvania, Jan. 11 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release on Jan. 9, 2025:
* * *
A new report from researchers at the University of Pennsylvania Perelman School of Medicine and Crescenz VA Medical Center evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individua . . .
* * *
A new report from researchers at the University of Pennsylvania Perelman School of Medicine and Crescenz VA Medical Center evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individua . . .